Professional Experience
Dr. Lukacova has accumulated extensive experience in both clinical and academic settings. She has held key positions in neuro-oncology, combining patient care with leadership in research projects and committees. Her experience spans advanced radiotherapy, tumor imaging, and collaborative research on treatment optimization for brain cancer patients.
- Current Role: Clinical Associate Professor, Aarhus University Hospital
- Previous Positions: Specialty Registrar, Chair of Radiotherapy Committee, Danish Neuro-Oncology Group (DNOG)
- Clinical Expertise: Brain tumor treatment, radiotherapy planning, proton therapy, and advanced imaging-guided therapy
- Leadership Roles: Mentorship of junior clinicians, supervision of research teams, and coordination of multidisciplinary treatment approaches
Academic Contributions
Dr. Lukacova actively contributes to the academic community, combining her clinical expertise with research and teaching. She is involved in mentoring PhD students, leading research projects, and delivering lectures at national and international conferences. Her academic work emphasizes improving diagnostic imaging, treatment planning, and personalized therapy in neuro-oncology.
- Research Interests: Gliomas, Glioblastomas, Proton Therapy, Diffusion Tensor Imaging
- Teaching Roles: Supervision of PhD students, development of neuro-oncology courses, and clinical teaching for residents
- Conference Engagement: Speaker at national and international oncology and radiotherapy meetings
- Mentorship: Guidance for junior clinicians and researchers in tumor imaging and radiotherapy protocols
Areas of Expertise
Dr. Lukacova’s expertise lies in treating complex brain tumors using advanced radiotherapy techniques and precision imaging. She emphasizes patient-centered care, combining medical knowledge with empathy and thorough communication. Her approach ensures that each treatment plan is customized to achieve the best possible outcomes while minimizing side effects.
- Conditions Treated: Gliomas, Glioblastomas, Gangliogliomas, Meningiomas, Arteriovenous Malformations
- Treatment Methods: Radiotherapy, Proton Therapy, Diffusion Tensor Imaging, Imaging-Guided Therapy
- Patient-Focused Care: Personalized therapy based on tumor characteristics, imaging data, and patient preferences
Publications and Research
Dr. Lukacova has contributed to numerous high-impact publications in neuro-oncology. Her research focuses on improving patient selection for proton therapy, optimizing imaging techniques, and advancing evidence-based radiotherapy protocols. These studies support clinical decisions and enhance treatment safety and effectiveness.
- Selected Publications:
- Prediction model for the selection of patients with glioma to proton therapy, 2025: Provides guidance on selecting optimal candidates for proton therapy.
- Mixed effect model confirms increased risk of image changes with increasing linear energy transfer in proton therapy of gliomas, 2025: Investigates imaging risks associated with proton therapy.
- ESTRO/EANO recommendation on reirradiation of glioblastoma, 2025: Offers evidence-based guidance for reirradiation strategies in glioblastoma patients.
Patient Care Philosophy
Dr. Lukacova prioritizes empathy, clear communication, and patient involvement in decision-making. She believes in educating patients and families about treatment options and outcomes. Her approach ensures that care is both scientifically advanced and compassionate.
- Communication: Clear explanations to help patients understand their condition and treatment
- Patient Education: Active engagement in treatment planning and informed decision-making
- International Patients: Accessible for consultations and treatment of patients from abroad
- Cultural Sensitivity: Respectful of diverse backgrounds and patient needs
Professional Affiliations
Dr. Lukacova is an active member of both national and international professional organizations, contributing to the advancement of neuro-oncology research and clinical practice. She participates in committees and leads initiatives to improve radiotherapy protocols.
- National: Danish Neuro-Oncology Group (DNOG), Chair of Radiotherapy Committee
- International: European Society for Radiotherapy and Oncology (ESTRO)
- Committee and Leadership Roles: Participation in guideline development and research strategy planning
FAQs
- Is Slávka Lukacova board-certified?
- Yes, she is board-certified in clinical oncology with a specialization in neuro-oncology, ensuring the highest standard of care.
- What types of surgeries does she perform?
- Dr. Lukacova primarily focuses on advanced radiotherapy and imaging-guided treatment. She does not perform surgical procedures.
- Does she treat international patients?
- Yes, Dr. Lukacova is open to international consultations and provides care tailored to patients from other countries.
- How long is the typical hospital stay?
- The length of stay depends on the treatment plan and individual patient needs, ranging from outpatient radiotherapy sessions to multi-day hospital visits.
- What languages does she speak?
- Dr. Lukacova communicates fluently in English and Danish, facilitating care for a diverse patient population.
